Form 8-K - Current report:
SEC Accession No. 0001654954-21-005626
Filing Date
2021-05-13
Accepted
2021-05-13 17:00:34
Documents
14
Period of Report
2021-05-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT celc-20211231.htm   iXBRL 8-K 49240
  Complete submission text file 0001654954-21-005626.txt   178019

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA celc-20211231.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celc-20211231_cal.xml EX-101.CAL 873
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celc-20211231_def.xml EX-101.DEF 1872
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celc-20211231_lab.xml EX-101.LAB 16429
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celc-20211231_pre.xml EX-101.PRE 12056
7 EXTRACTED XBRL INSTANCE DOCUMENT celc-20211231_htm.xml XML 4479
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-38207 | Film No.: 21920552
SIC: 8071 Services-Medical Laboratories